1. 熊祎,张永兰,杜忠东*.101例川崎病冠状动脉巨大瘤患儿中长期随访.中华儿科杂志.2021.59(2).101-106.核心期刊 |
2. 胡慧敏,赵春娜,杜宏武,杜忠东*.血清meprin-α在儿童川崎病诊断中的临床应用价值.中国医学前沿杂志(电子版).2020.12(1).141-144.核心期刊 |
3. 熊祎,杜忠东*.肿瘤坏死因子阻断剂在川崎病丙种球蛋白无反应患儿的应用.中华儿科杂志.2020.58 (03).248-251.核心期刊 |
4. Li Jinying, An Shuhua*, Du Zhongdong*.Familial Interstitial Lung Disease Caused by Mutation of the STING1 Gene .Frontier in Pediatrics.2020.8.543.SCI |
5. 汪顺雨,刘庚英,杜忠东*.川崎病合并巨噬细胞活化综合征的临床研究进展.中华儿科杂志.2020.58(11).953-956.核心期刊 |
6. Liu Gengying, Wang Shunyu, Du Zhongdong*.Risk factors of intravenous immunoglobulin resistance in children with Kawasaki disease: a meta-analysis of case-control studies .Frontier in Pediatrics.2020.8.187.SCI |
7. Cui J,Zhou Y, Hu H, Zhao L, Du Z*, Du H*.PGK1 as an immune target in Kawasaki disease.Clinical and Experimental Immunology.2018.194.371–379.SCI |
8. Hu HM, Zhang XL, Zhang WL, Huang DS, Du ZD* .Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor.Chinese Medical Journal.2018.131(12).1450-1456.SCI |
9. Hu HM, Zhang XL, Zhang WL, Huang DS, Du ZD*.New biomarkers of Kawasaki disease by urine proteomic analysis.FEBS Open Bio.2018.12.1-11.SCI |
10. Zhang XL, Duan XM, Wang FY, Zhang X, Sun Y, Ma N, Du ZD*. .An Infant with Abernethy Malformation Associated with Heterotaxy and Pulmonary Hypertension .Chin Med J (Engl)..2017.20;130(18).2257-2258.SCI |
11. Zhang XX, Du ZD*, Wen SG, Sun XP. .Echocardiographic Evaluation of Coronary Abnormalities and Cardiac Function in a Murine Model of Kawasaki Disease Using High-frequency Ultrasound .Chin Med J (Engl)..2017.20;130(12).1467-1474.SCI |
12. 张晓琳,杜忠东*,金兰中,王芳韵,马宁,张鑫,马桂琴,郑琳,卫海燕,李静雅,李培,孙妍,杨娇.川崎病并冠状动脉血栓35例超声心动图随访及临床回顾分析.中华实用儿科临床杂志.2017.32(21):.1653-1656..核心期刊 |
13. 赵春娜,杜忠东*,高灵灵.儿童川崎病冠状动脉病变危险因素分析.中华实用儿科临床杂志.2016.31(9).20-23.核心期刊 |
14. Zhao Chun-na, Du Zhong-dong*, Gao Linglin.Corticosteroid therapy might be associated with the development of coronary aneurysm in children with Kawasaki disease.Chinese Medical Journal.2016.129(8).922-928.SCI |
15. Ma Le, Guan Yun-qian, Du Zhong-dong*.Salvianolic acid B down-regulates MMP-9 activity and expression in TNF-α-induced cell model of Kawasaki disease.Chinese Medical Journal.2015.128(19).2658-2663.SCI |
16. Duan C, Du ZD*, Wang Y, Jia LQ.Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease.World Journal of Pediatrics.2014.10(3).232-237.SCI |
17. 上官文,杜忠东*,杨海明,张艳兰,宋铭晶,董伟 .丙种球蛋白下调川崎病小鼠NF-κB/MMP-9的表达及活性.中华医学杂志.2014.94(12).938-943.核心期刊 |
18. Shangguan W, Du ZD*, Yang HM, Zhang YL, Song MJ, Dong W..IVIG suppresses the up-regulation of the NF-κB/MMP-9 pathway in a mouse model of Kawasaki disease .Experimental & Clinical Cardiology.2014.(8).4136-4154.SCI |
19. Liu JF, Chen Z, Du ZD*, Lu DX. .Granulocyte colony-stimulating factor ameliorates coronary artery elastin breakdown in a mouse model of Kawasaki disease.Chinese Medical Journal.2014.127(21).3712-3717.SCI |
20. 张艳兰,杜忠东*,杨海明,上官文,董伟,宋铭晶.川崎病小鼠肿瘤坏死因子α/核因子κB/基质金属蛋白酶9通路研究.中国循证儿科杂志.2014.9(1).59-63.核心期刊 |
21. Yang HM, Du ZD*, Fu PP. .Clinical features of recurrent Kawasaki disease and its risk factors.European Journal of Pediatrics.2013.172.1641-1647.SCI |
22. 杨海明,杜忠东*,上官文,张艳兰,董伟,宋铭晶,郑枝兰.正常小鼠冠状动脉的超声成像技术分析.中国比较医学研究.2013.23(9).27-30.核心期刊 |
23. 杨海明,杜忠东*,上官文,张艳兰,董伟,宋铭晶,郑枝兰. 川崎病小鼠模型心脏超声评价.中国比较医学研究.2013.23(11).54-60.核心期刊 |
24. 郑远征,杜忠东*.华法林联合阿司匹林治疗对川崎病合并巨大冠状动脉瘤预后的影响.中华实用儿科临床杂志.2013.28(9).649-652.核心期刊 |
25. 李霞,杜忠东*,周仲蜀,孔健,潘岳松.2003-2009年北京市部分医院住院儿童疾病谱及病死原因演变.中国实用儿科杂志.2013.28(7).537-539.核心期刊 |
26. 张永兰,杜忠东*,付培培 .儿童多发性大动脉炎58例临床特点分析.中国医刊.2013.48(7).40-42.核心期刊 |
27. 张永兰,杜忠东*,付培培.不同剂量静脉丙种球蛋白或加甲泼尼龙治疗无反应川崎病患儿疗效观察.中国循证儿科杂志.2013.8(3).220-223.核心期刊 |
28. Fu PP, Du ZD*, Pan YS. .Novel predictors of intravenous immunoglobulin resistance in Chinese children with Kawasaki disease .Pediatric Infectious Disease Journal.2013.32(8).e319-23.SCI |
29. Chen Z, Du ZD*, Liu JF, Lu DX, Li L, Guan YQ, Wan SG .Endothelial progenitor cells transplantation in a Kawasaki disease model.Chinese Medical Journal.2012.125(13).2295-2301.SCI |
30. Liu JF, Du ZD*, Chen Z, Lu DX, Guan YQ, Wan SG.Endothelial progenitor cell down-regulation in a mouse model of Kawasaki disease.Chinese Medical Journal.2012.125(3).496-501.SCI |
31. 刘俊峰,杜忠东*,陈植,关云谦,万岁桂.全骨髓培养法扩增小鼠内皮祖细胞的实验研究.中国组织工程研究.2012.16(36).6762-6766.核心期刊 |
32. 付培培,杜忠东*,潘岳松.2002-2010年北京儿童医院川崎病住院患儿的临床分析.实用儿科临床杂志.2012.27(9).661-664.核心期刊 |
33. 付培培,杜忠东*,潘岳松.单中心不完全川崎病回顾性分析.中国循证儿科杂志.2012.7(4).293-297.核心期刊 |
34. 陈植,刘俊峰,杜忠东*,万岁桂,关云谦.粒细胞集落刺激因子对川崎病小鼠模型内皮祖细胞及其冠状动脉损的影响.中华儿科杂志.2012.50(10).788-792.核心期刊 |
35. 付培培,杜忠东*.静脉注射丙种球蛋白无反应型川崎病的诊治进展.实用儿科临床杂志.2012.27(21).1679-1682.核心期刊 |
36. 李霞,杜忠东*.风湿热的一级预防及急性链球菌咽炎的诊治.实用儿科临床杂志.2011.26(22).1765-1768.核心期刊 |
37. 段超,杜忠东(通讯).血管内皮祖细胞与川崎病冠状动脉并发症的血管新生.中华儿科杂志.2011.49(5).397-400.核心期刊 |
38. 段超,杜忠东(通讯),王玉,贾立群.川崎病冠脉瘤患儿远期血管内皮功能的研究.中国当代儿科杂志.2011.13(5).373-376.核心期刊 |
39. 潘岳松,杜忠东(通讯),沈颖.重视儿科药物临床试验的伦理审查(述评.中华儿科杂志.2011.49(7).485-488.核心期刊 |
40. 段超, 杜忠东*, 张桂荣,万岁桂,孙雪静.川崎病冠脉瘤患儿远期血管内皮祖细胞及炎症因子的研究.中国实用儿科杂志.2010.25(10).759-762.核心期刊 |
41. 刘冲,杜忠东*,李霞,段超.住院儿童高血压的病因分析及鉴别诊断.首都医科大学学报.2010.31 (2).187-191.核心期刊 |
42. 杜忠东,赵地,杜军保,鲁珊,衣京梅,侯安存,周忠蜀,丁国芳暨北京小儿川崎病流行病学调查协作组。.静脉注射丙种球蛋白应用时间对川崎病疗效的影响.中华医学杂志.2009.89(26).1841-1843.核心期刊 |
43. 郭慧琳,杜忠东*,彭芸,曾津津.超声心动图和64层螺旋CT在川崎病冠状动脉瘤随访中的应用价值.中国循证儿科杂志.2009.4(2).136-140.核心期刊 |
44. 鲁炜慧,杜忠东*.基于北京市儿童川崎病6年流行病学资料的实验室指标分析.中国循证儿科杂志.2008.3(5).356-361.核心期刊 |
45. 刘冲,杜忠东*.心肌炎的无创性影像学检查进展.中华儿科杂志.2008.46(10).795-797.核心期刊 |
46. 段超,杜忠东*.63例川崎病合并冠状动脉瘤的中远期随诊.中国实用儿科杂志.2008.24(1).37-40.核心期刊 |
47. 林瑶,杜忠东*,杜军保,赵地,刘冲,郭慧琳.6个月以下婴儿川崎病138例临床分析.中华儿科杂志.2008.46(5).382-383.核心期刊 |
48. 杜忠东,赵地,杜军保,鲁珊,衣京梅,侯安存,周忠蜀,丁国芳.不同静脉丙种球蛋白给药方法治疗川崎病的效果比较.中华医学杂志.2007.87(44).3119-3121.核心期刊 |
49. 杜忠东.心律失常的电生理基础及分子遗传学.实用儿科临床杂志.2007.22(1).1-3.无 |
50. 郭惠琳, 杜忠东.冠状动脉CTA和MRA在川崎病中的应用.中华儿科杂志.2007.45(6).474-476.无 |
51. 杜忠东,贾立群,张永兰,王玉.用超声检测川崎病合并体循环动脉瘤的研究.中华儿科杂志.2007.45(5).395-396.无 |
52. 林瑶,杜忠东.川崎病冠状动脉病变的治疗现状和进展.中华儿科杂志.2007.44(12).901-903.无 |
53. Du ZD, Zhao D, Du JB.The Epidemiologic Study on Kawasaki Disease in Beijing from 2000 Through 2004. .Pedidatric Infectious Disease Journal.2007.26(5).449-451.SCI |
54. 林利,杜忠东.晕厥的病因分析及鉴别诊断.实用儿科临床杂志.2006.21(13).808-810.无 |
55. 杜忠东,张永兰,赵地,杜军保.静脉丙种球蛋白无反应性川崎病的治疗及危险因素分析.中国实用儿科杂志.2006.21(10).738-741.无 |
56. 张永兰,杜忠东.小儿川崎病冠状动脉损伤的危险因素研究.中国实用儿科杂志.2006.21(10).742-744.无 |
57. 杜忠东,梁璐,李仲智.小儿扩张型心肌病的限制性心功能异常及其临床意义.首都医科大学学报.2005.26.536-539.无 |
58. Du Z-D*,Cao L,Liang L,Li ZZ .Increased pulmonary arterial pressure in children with nephrotic syndrome. 2004;89:866-870..Archives of Disease in Childhood.2004.89.866-870.SCI |
59. 梁璐,杜忠东.遗传性长QT间期综合征LQTS1的基因的新突变.中华儿科杂志.2003.41(10).724-727.无 |
60. Du Z-D, Cao Q-L, Rhodes J, Heitschmidt M, Hijazi Z.Choice of device size and results of transcatheter Closure of atrial septal defect using the Amplatzer Septal Occluder.Journal of Interventinal Cardiology.2002.15.287-292.SCI |
61. Du Z-D, Cao Q-L, Joseph A, Heitschmidt M, Hijazi Z.Transcatheter Closure of Patent Foramen Ovale in Patients with Paradoxical Embolism: Intermediate-term Risk of Recurrent Neurological Events.Catheter Interventional Cardiology.2002.55.189-194.SCI |
62. Du Z-D, Hijazi Z, Kleinman CS.Comparison of Transcatheter Amplatzer Device and Surgical Closure of Atrial Septal Defect: results of a Multi-center Non-randomized Controlled Study.Journal of American College of Cardiology .2002.39.1836-1844.SCI |
63. Du Z-D, Koenig P, Cao QL, Waight D, Heitschmidt M, Hijazi ZM.Comparison of transcatheter closure of secundum atrial septal defect using the Amplatzer septal occluder associated with deficient versus sufficient rims .American Journal of Cardiology .2002.90.865-869.SCI |
64. Du Z-D*, Zhang TH, Li T, Liang L, Nakumura T, Yanagawa H, Kawasaki T .Epidemiologic pictures of Kawasaki disease in Beijing from 1995 through 1999.Pediatric Infectious Disease Journal.2002.21.103-107.SCI |